`By:
`Justin B. Kimble (JKimble-IPR@bcpc-law.com)
`Bragalone Conroy PC
`2200 Ross Ave.
`Suite 4500 – West
`Dallas, TX 75201
`Tel: 214.785.6670
`Fax: 214.786.6680
`
`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`FITBIT, INC.,
`Petitioner,
`
`v.
`
`VALENCELL, INC.,
`Patent Owner.
`
`Case IPR2017-003191
`U.S. Patent No. 8,923,941
`
`
`PRO HAC VICE MOTION TO ADMIT ATTORNEY
`JEFFREY R. BRAGALONE PURSUANT TO 37 C.F.R. § 42.10(c)
`
`
`
`EXHIBIT 2008: DECLARATION OF JEFFREY R. BRAGALONE
`
`
`Mail Stop PATENT BOARD
`Patent Trial and Appeal Board
`U.S. Patent & Trademark Office
`P.O. Box 1450
`Alexandria, Virginia 22313-1450
`
`
`
`
`1 Case IPR2017-01555 has been joined with this proceeding.
`
`
`
`Case IPR2017-00319
`U.S. Pat. No. 8,923,941
`
`I, Jeffrey R. Bragalone, make the following declaration based on my own
`
`personal knowledge and, if called to testify before the court, could and would testify
`
`as follows:
`
`1. I am a shareholder with the law firm of Bragalone Conroy PC, located at 2200
`
`Ross Avenue, Suite 4500-West, Dallas, TX 75201.
`
`2. I am a member in good standing of the Texas State Bar.
`
`3. I have never been subject to any suspensions or disbarments from practice
`
`before any court or administrative body.
`
`4. None of my applications for admission to practice before any court or
`
`administrative body has ever been denied.
`
`5. I have never been sanctioned nor had contempt citations imposed by any court
`
`or administrative body.
`
`6. I have read and will comply with the Office Patent Trial Practice Guide and
`
`the Board’s Rules of Practice for Trials set forth in part 42 of 37 C.F.R.
`
`7. I will be subject to the USPTO Rules of Professional Conduct set forth in 37
`
`C.F.R. §§ 11.101 et. seq. and disciplinary jurisdiction under 37 C.F.R.
`
`§ 11.19(a).
`
`8. During the past six years, I have applied to appear or have appeared pro hac
`
`vice before the PTAB in 31 other proceedings, all of which have been granted.
`
`In addition, I have appeared pro hac vice in the following proceedings:
`
`
`
`
`
`
`
`Case IPR2017-00319
`U.S. Pat. No. 8,923,941
`
`IPR2014-00785;
`
`IPR2014-00810;
`
`IPR2014-00824;
`
`IPR2014-00825;
`
`CBM2014-00166;
`
`IPR2014-01092;
`
`IPR2014-01094;
`
`IPR2014-01095;
`
`IPR2014-01096;
`
`IPR2014-01097;
`
`IPR2014-01278;
`
`IPR2014-01282;
`
`IPR2014-01283
`
`IPR2014-01357;
`
`IPR2014-01359;
`
`IPR2014-01362;
`
`IPR2015-00153;
`
`IPR2015-00155;
`
`IPR2015-00156;
`
`IPR2015-00487;
`
`IPR2015-00506;
`
`IPR2015-01666
`
`(joined);
`
`IPR2015-01717
`
`(joined);
`
`IPR2015-01866;
`
`IPR2015-01867;
`
`IPR2015-01868;
`
`PGR2016-0044;
`
`IPR2016-01123; IPR2016-01220; IPR2016-01362; and CBM2017-00034.
`
`I have familiarity with the subject matter at issue in the proceeding. I have
`
`represented Valencell in previous patent litigation, which representation allowed me
`
`to become familiar with the subject matter at issue in the proceeding, i.e.,
`
`physiological monitoring technology. Specifically, in two cases in the Eastern
`
`District of North Carolina. See, e.g., Valencell, Inc. v. Apple, Inc., No. 5:16-cv-00001
`
`(E.D. N.C., filed Jan. 4, 2016); see also Valencell, Inc. v. Fitbit, Inc., No. 5:16-cv-
`
`00002 (E.D. N.C., filed Jan. 4, 2016). As counsel in those actions, I have become
`
`very familiar with the subject matter at issue in this proceeding, e.g., physiological
`
`monitoring technology. Furthermore, in those lawsuits, I have developed
`
`infringement allegations that assert the patent-at-issue in this proceeding against
`
`various products, including, for example watches with heart rate monitoring
`
`functionality. In my role as counsel in those litigations, I have spent significant time
`
`
`
`
`
`
`
`Case IPR2017-00319
`U.S. Pat. No. 8,923,941
`
`learning about physiological monitoring technology such as that found in the patent-
`
`at-issue in this proceeding. Moreover, I have analyzed the prior art involved in this
`
`petition as well as in the petitions for related patents.
`
`I declare under penalty of perjury that the foregoing is true and correct.
`
`Executed this 14th day of September, 2020.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Jeffrey R. Bragalone
`Bragalone Conroy PC
`2200 Ross Ave., Suite 4500-West
`Dallas, TX 75201
`Phone: (214) 785-6670
`Email: jbragalone@bcpc-law.com
`
`
`
`
`
`
`
`
`
`
`
`